An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin’s...

Por Mauro, Endri, Pedata, Mariangela, Ermacora, Anna, Mazzaro, Cesare
Publicado em 2012

SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival

Por Mohelnikova-Duchonova, Beatrice, Strouhal, Ondrej, Hughes, David J., Holcatova, Ivana, Oliverius, Martin, Kala, Zdenek, Campa, Daniele, Rizzato, Cosmeri, Canzian, Federico, Pezzilli, Raffaele, Talar-Wojnarowska, Renata, Malecka-Panas, Ewa, Sperti, Cosimo, Federico Zambon, Carlo, Pedrazzoli, Sergio, Fogar, Paola, Milanetto, Anna Caterina, Capurso, Gabriele, Delle Fave, Gianfranco, Valente, Roberto, Gazouli, Maria, Malleo, Giuseppe, Teresa Lawlor, Rita, Strobel, Oliver, Hackert, Thilo, Giese, Nathalia, Vodicka, Pavel, Vodickova, Ludmila, Landi, Stefano, Tavano, Francesca, Gioffreda, Domenica, Piepoli, Ada, Pazienza, Valerio, Mambrini, Andrea, Pedata, Mariangela, Cantore, Maurizio, Bambi, Franco, Ermini, Stefano, Funel, Niccola, Lemstrova, Radmila, Soucek, Pavel
Publicado no Sci Rep (2017)